C. Albac

Long‐lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5‐selective GABAA inverse agonist

Y. Hérault, J. Delgado-García, A. Gruart, 2020, British journal of pharmacology.

In vivo 1H MRS study in microlitre voxels in the hippocampus of a mouse model of Down syndrome at 11.7 T

R. Valabrègue, B. Delatour, L. Dauphinot, 2014, NMR in biomedicine.

Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome

R. Bartesaghi, M. Grilli, M. Potier, 2020, Neurobiology of Disease.

Neural Androgen Receptor Deletion Impairs the Temporal Processing of Objects and Hippocampal CA1-Dependent Mechanisms

J. Billard, Carlos Dombret, S. Mhaouty-Kodja, 2016, PloS one.

DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives

B. Delatour, J. Delabar, M. Potier, 2018, Scientific Reports.

Increases of SET level and translocation are correlated with tau hyperphosphorylation at ser202/thr205 in CA1 of Ts65Dn mice

C. Guihenneuc‐Jouyaux, M. Potier, B. Allinquant, 2016, Neurobiology of Aging.

Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models

M. Potier, V. Tybulewicz, E. Fisher, 2017, Neurobiology of Disease.

Revisiting the neural role of estrogen receptor beta in male sexual behavior by conditional mutagenesis

Matthieu Keller, M. Keller, S. Mhaouty-Kodja, 2016, Hormones and Behavior.